There are 2867 resources available
Presentation by Expert
Presenter: David SP Tan
Session: Should all advanced ovarian cancer patients receive a PARPi in first-line therapy?
Resources:
Slides
Webcast
Presentation by Expert
Presenter: Clemens-Martin Wendtner
Session: Chronic lymphocytic leukemia (CLL): What is the optimal first-line therapy?
Resources:
Slides
Webcast
Presentation by Expert
Presenter: Alejandro Forner
Session: Selection of first-line and subsequent treatments in HCC
Resources:
Slides
Webcast
Discussion led by Chair
Presenter: Ines Vaz Luis
Session: How to incorporate digital medicine in survivorship care after breast cancer
Resources:
Slides
Webcast
Optimizing local treatment for brain metastasis in lung cancer
Presenter: Matthias Guckenberger
Session: Multidisciplinary management of brain metastases with or without driver oncogene
Resources:
Slides
Webcast
Discussion led by Chair
Presenter: Anja Lorch
Session: Germ cell tumors: Prognostic factors, managing poor-risk and progressive/refractory disease
Resources:
Webcast
Discussion led by Chair
Presenter: Frederik Marmé
Session: Should all advanced ovarian cancer patients receive a PARPi in first-line therapy?
Resources:
Slides
Webcast
Discussion led by Chair
Presenter: Carol Moreno
Session: Chronic lymphocytic leukemia (CLL): What is the optimal first-line therapy?
Resources:
Slides
Webcast
Discussion led by Chair
Presenter: Robin Katie Kelley
Session: Selection of first-line and subsequent treatments in HCC
Resources:
Slides
Webcast
Role and reliability of systemic treatment for brain metastasis in lung cancer
Presenter: Lizza Hendriks
Session: Multidisciplinary management of brain metastases with or without driver oncogene
Resources:
Slides
Webcast